Correction: Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer (Hurthle cell carcinoma)

Yiquan Xiong; Qiuyang Zhao; Zhi Li; Shuntao Wang; Hui Guo; Zeming Liu; Tao Huang

doi:10.18632/oncotarget.25000

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer (Hurthle cell carcinoma)

PDF | How to cite

Oncotarget. 2018; 9:16273-16273. https://doi.org/10.18632/oncotarget.25000

Metrics: PDF 1427 views | ?

Yiquan Xiong^1,*, Qiuyang Zhao^1,*, Zhi Li¹, Shuntao Wang¹, Hui Guo¹, Zeming Liu¹ and Tao Huang¹

¹ Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
^* These authors contributed equally to this work

Published: March 23, 2018

This article has been corrected: The proper name of the institution is as follows:

¹Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

Original article: Oncotarget. 2017; 8:101362-101371 DOI: https://doi.org/10.18632/oncotarget.20732.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25000

Publication Alerts

Corrections:

Correction: Propensity score matching analysis of the prognosis for the rare oxyphilic subtype of thyroid cancer (Hurthle cell carcinoma)